125 related articles for article (PubMed ID: 10212646)
41. Screening for cervical cancer in an African setting.
Cronjé HS; Beyer E
Int J Gynaecol Obstet; 2007 Aug; 98(2):168-71. PubMed ID: 17585915
[TBL] [Abstract][Full Text] [Related]
42. Adequacy of cellular material in split-sampling of cervical scrapings for routine cancer screening: an analysis of 702 smears.
Othman N; Othman NH
Malays J Pathol; 2012 Dec; 34(2):115-21. PubMed ID: 23424773
[TBL] [Abstract][Full Text] [Related]
43. [Liquid-based cervical cytology ThinPrep screening in Hungary].
Bak M; Séberné Éll M; Bóka M; Veleczki Z; Nyári T; Pete I; Szentirmay Z
Orv Hetil; 2014 May; 155(18):708-14. PubMed ID: 24776385
[TBL] [Abstract][Full Text] [Related]
44. Unsatisfactory SurePath liquid-based Papanicolaou tests: causes and significance.
Alsharif M; McKeon DM; Gulbahce HE; Savik K; Pambuccian SE
Cancer; 2009 Feb; 117(1):15-26. PubMed ID: 19347825
[TBL] [Abstract][Full Text] [Related]
45. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.
Karnon J; Peters J; Platt J; Chilcott J; McGoogan E; Brewer N
Health Technol Assess; 2004 May; 8(20):iii, 1-78. PubMed ID: 15147611
[TBL] [Abstract][Full Text] [Related]
46. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
48. Merits and pitfalls of normal saline rehydrated air-dried cervical smears over conventional wet.fixed PAP smears: A comparative study.
Kamble SA; Dombale VD; Shah F
Indian J Pathol Microbiol; 2022; 65(1):100-104. PubMed ID: 35074972
[TBL] [Abstract][Full Text] [Related]
49. Effects of speculum lubrication on cervical smears for cervical cancer screening: A double blind randomized clinical trial.
Ilika CP; Eleje GU; Chiemeka ME; Ilika FN; Ikechebelu JI; Ilika VC; Ugwu EO; Ofor IJ; Ogelle OM; Umeononihu OS; Mamah JE; Olisa CL; Ezeigwe CO; Nwankwo ME; Ofojebe CJ; Okafor CC; Ekwebene OC; Nnabuchi OK; Okafor CG
PLoS One; 2024; 19(5):e0292207. PubMed ID: 38787830
[TBL] [Abstract][Full Text] [Related]
50. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
51. An inpatient cervical cancer screening program to reach underserved women.
Richards LA; Klemm P
J Obstet Gynecol Neonatal Nurs; 2000; 29(5):465-73. PubMed ID: 11012125
[TBL] [Abstract][Full Text] [Related]
52. Use of a liquid-based, thin-layer Pap test in a community hospital. Impact on cytology performance and productivity.
Sass MA
Acta Cytol; 2004; 48(1):17-22. PubMed ID: 14969176
[TBL] [Abstract][Full Text] [Related]
53. The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011).
Whop LJ; Garvey G; Baade P; Cunningham J; Lokuge K; Brotherton JM; Valery PC; O'Connell DL; Canfell K; Diaz A; Roder D; Gertig D; Moore SP; Condon JR
Cancer; 2016 May; 122(10):1560-9. PubMed ID: 27149550
[TBL] [Abstract][Full Text] [Related]
54. Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples.
Belinson JL; Pan QJ; Biscotti C; Wu LY; Pretorius RG; Li L; Elson P; Rong SD; Zhang WH; Qiao YL
Acta Cytol; 2002; 46(3):470-4. PubMed ID: 12040639
[TBL] [Abstract][Full Text] [Related]
55. Comparison of Pap smear screening results between Akha hill tribe and urban women in Chiang Rai province, Thailand.
Kritpetcharat O; Wutichouy W; Sirijaichingkul S; Kritpetcharat P
Asian Pac J Cancer Prev; 2012; 13(11):5501-4. PubMed ID: 23317207
[TBL] [Abstract][Full Text] [Related]
56. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening.
Lee KR; Ashfaq R; Birdsong GG; Corkill ME; McIntosh KM; Inhorn SL
Obstet Gynecol; 1997 Aug; 90(2):278-84. PubMed ID: 9241308
[TBL] [Abstract][Full Text] [Related]
57. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
[TBL] [Abstract][Full Text] [Related]
58. Correlation of Cervical Pap Smear with Biopsy in the Lesion of Cervix.
Dhakal R; Makaju R; Sharma S; Bhandari S; Shrestha S; Bastakoti R
Kathmandu Univ Med J (KUMJ); 2016 Jul-Sept.; 14(55):254-257. PubMed ID: 28814689
[TBL] [Abstract][Full Text] [Related]
59. The preparation of additional smears from a cervical scrape: impact on the rate of detection of cervical neoplasia.
Al-Awadhi R; Byrne M; Coleman DV
Cytopathology; 2001 Jun; 12(3):151-6. PubMed ID: 11380556
[TBL] [Abstract][Full Text] [Related]
60. Breast and cervical cancer screening in obese minority women.
Ferrante JM; Chen PH; Jacobs A
J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
